SeQuent Scientific Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA220120
EBIT16169
Earning Per Share31
Expenses1,1501,303
Net Profit10445
Net Profit Margin83
Operating Profit Margin169
Profit Before Tax13753
Dividends Per Share10
Operation Revenue1,3701,424

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of SeQuent Scientific is 120 as of 2/22/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20092009200920092021
Operating Activities-5-5-5-5115
Investing Activities-29-29-29-2910
Financing Activities34343434-139
Others00000
Net Cash Flow-0-0-0-0-14

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of SeQuent Scientific is 115 as of 2/22/2024